학술논문
1620P A phase II study of perioperative nalirifox in patients with resectable pancreatic ductal adenocarcinoma (rPDAC): Survival update and biomarkers analysis of the NITRO trial
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S897-S897
Subject
Language
ISSN
0923-7534